Pharmaceuticals

Method for Repurposing FDA-approved Therapeutics & Composition for Treating Mesothelioma

Metabolically-fit Immunotherapies Portfolio

Cyclodepsipeptide compounds presenting anti-cancer and anti-infective activity, and their synthesis

Creation of Multivalent Aptamers to Target Effector T Cells to Attack Tumor Cells

Carbohydrate-Mediated Tumor Targeting

Methods and Compositions Related to Glycoprotein-Immunoglobulin Fusions

Bi-specific Antibodies as a Therapeutic for Alzheimer’s Disease

Reducing Oxidative Stress with Multifunctional Radical Quenchers

Plant-based Production of an Antibody Therapeutic for West Nile Virus

QSOX1 as an anti-neoplastic drug target